mohmad mehdi khadembashiri

Dr. mohmad mehdi khadembashiri


Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 December 2023 in IJC Heart & Vasculature
Verified
Journal Article
Open access
MAMohammad Ahmadi
Mohammad Ahmadi
SAShana Ahadi
Shana Ahadi
MKMohammad Amin Khadembashiri
Mohammad Amin Khadembashiri
MKmohmad mehdi khadembashiri
mohmad mehdi khadembashiri
MMMehrdad Mahalleh
Mehrdad Mahalleh
ASAli Akbari Sari
Ali Akbari Sari
Despite the burden of ischemic heart disease (IHD), there remains a paucity of research on the incidence, mortality, and burden of this condition in the Middle East and North Africa (MENA) regions. This study aimed to evaluate the epidemiology and the risk factors associated with IHD in the MENA region. This study was performed based on the GBD study 2019 data. We retrieved the data related to the epidemiology and burden of IHD, including prevalence, incidence, years of life lost due to premature death (YLLs), years lived with disability (YLDs), and mortality at the global level and in MENA countries across years and sexes. IHD accounted for approximately 2.55 million (95 % UI 2.29–2.83) incident cases in MENA in 2019, with an age-standardized incidence rate of 613.87 (95 % UI 555.84–675.16) per 100 000 people, which has decreased by 9 % between 1990 and 2019. IHD accounted for 11.01 % of DALYs causes in MENA in 2019, an increase of 68 % compared to 1990. The DALYs rate from IHD increased with age in both men and women and was higher in men than in women in all age groups, except 85–89 years age-group, in 2019. The age-standardized prevalence and incidence of IHD are decreasing in MENA. However, this reduction is lower than the global level, which can be due to a weaker performance of the countries in the region in reducing the prevalence and incidence of the disease compared to the global average.

16 July 2024 in BMC Cardiovascular Disorders
Verified
Journal Article
Open access
PDF file
MYMohammad Yaghoubi
Mohammad Yaghoubi
PRParvaneh Hamian Roumiani
Parvaneh Hamian Roumiani
FNFateme Nozari
Fateme Nozari
SSSaba Simiyari
Saba Simiyari
AAAlireza Azarboo
Alireza Azarboo
MKMohammad Amin Khadembashiri
Mohammad Amin Khadembashiri
Background: Atrial fibrillation and flutter (AFF) are the most common cardiac arrhythmias globally, contributing to substantial morbidity and mortality. The Middle East and North Africa (MENA) region face unique challenges in managing cardiovascular diseases, including AFF, due to diverse sociodemographic factors and healthcare infrastructure variability. This study aims to comprehensively evaluate the burden of AFF in MENA from 1990 to 2019. Methods: Data were obtained from the Global Burden of Diseases Study 2019, a comprehensive source incorporating diverse data inputs. The study collected global, regional, and national Age-Standardized Incidence Rate (ASIR), Age-Standardized Mortality Rate (ASMR), and Age-Standardized Disability-Adjusted Rate (ASDR), Mortality across sex, age groups, and years. LOESS regression was employed to determine the relationship between age-standardized rates attributed to AFF and Socio-Demographic Index (SDI). Results: The study found minimal change in ASIR of AFF in MENA from 1990 to 2019, with a slight increase observed in ASMR and ASDR during the same period. Notably, AFF burden was consistently higher in females compared to males, with age showing a direct positive relationship with AFF burden. Iraq, Iran, and Turkey exhibited the highest ASIR, while Qatar, Bahrain, and Oman had the highest ASMR and ASDR in 2019. Conversely, Kuwait, Libya, and Turkey displayed the lowest ASMR and ASDR rates. Conclusion: This study underscores the persistent burden of AFF in MENA and identifies significant disparities across countries. High systolic blood pressure emerged as a prominent risk factor for mortality in AFF patients. Findings provide crucial insights for policy-making efforts, resource allocation, and intervention strategies aimed at reducing the burden of cardiovascular diseases in the MENA region.

4 November 2023 in Journal of Community Hospital Internal Medicine Perspectives
Verified
Journal Article
Open access
PDF file
HRHanieh Radkhah
Hanieh Radkhah
MOMehrnia Omidali
Mehrnia Omidali
AHAlireza Hejrati
Alireza Hejrati
RBRazman Arabzadeh Bahri
Razman Arabzadeh Bahri
SASara Arefi
Sara Arefi
BABahareh Shateri Amiri
Bahareh Shateri Amiri
Background: : Long-COVID refers to lasting unspecific symptoms like fatigue, decreased concentration and sleep issues after infection which persist for at least three months and cannot be attributed to other causes. Previous studies surveyed the association between inflammatory markers like C - reactive protein (CRP) at hospital admission and long-COVID symptoms in the preceding months. Post-COVID syndrome can affect one-third of patients. Thus early diagnosis can assist in reducing burdens on public health. We attempted to see any correlations between complete blood count (CBC) markers (like red blood cell (RBC), white blood cell (WBC), Neutrophil to lymphocyte ratio (NLR), etc.) at hospital admission and long COVID symptoms at a 6-month follow-up. Methods: 167 patients (44.9% females, mean age 49 years old) answered semi-structural interviews through telemedicine which focused on the three prominent symptoms: fatigue, loss of concentration and decreased libido. Results: Two third of patients have symptoms of long COVID and others do not have. NLR in the symptomatic group was statically higher. Patients who underwent decreased libido at a 6-month follow-up had significantly more severe lymphopenia (p=0.028) and higher NLR values (p-value=0.007). Poor mental concentration is associated with high WBC in numbers and polymorphonuclear (PMN) count. Other symptoms do not correlate with blood markers. Conclusion: Utilizing available data like CBC can help predict the upcoming symptoms of previously hospitalized patients and further measures like rehabilitation. Additional investigations should be done on the effect of COVID vaccination on converting long COVID. Different variants of the virus may have different results.

9 April 2025 in Journal of Medical Imaging and Interventional Radiology
Verified
Journal Article
Open access
PDF file
AHArmin Hoveidaei
Armin Hoveidaei
SSSoheil Heidari Some’eH
Soheil Heidari Some’eH
RGReza Rahimzadeh Goradel
Reza Rahimzadeh Goradel
HDHamidreza Didar
Hamidreza Didar
MKMohammad Saeid Khonji
Mohammad Saeid Khonji
MMMaryam Mohseny
Maryam Mohseny
Introduction: Radiology plays an important role in medical diagnoses, and proper techniques are critical in disease diagnosis. As a result, physicians’ and medical students’ knowledge of this field, as well as their mastery of imaging techniques, is critical. The purpose of this study was to assess Iranian medical students, residents, and physicians’ knowledge of the fundamentals of various imaging methods, the amount of ionizing radiation in each type of imaging, and diagnostic imaging techniques. Methods: This is a cross-sectional study in which 454 general practitioners, residents and medical interns in Iran have filled out an online questionnaire regarding the details of different imaging methods. The results after correcting and scoring this the questionnaires were subjected to statistical analysis. Results: Only 5.2% of the questions about the amount of ionizing radiation in all types of imaging were correctly answered. Twenty two% of interns, 16% of general practitioners, and 23% of residents had accurate information about the side effects of diagnostic imaging. Ninety four% of participants were aware that the sonography method does not use ionizing radiation. Also, while 90% of participants were correct about the computed tomography (CT) scan, the percentage of those who were correct about the barium, positron emission tomography (PET), mammography, and Magnetic resonance imaging (MRI) was lower. Conclusion: This study reveals a significant knowledge gap among Iranian medical professionals regarding ionizing radiation risks and dosages, despite frequent use of CT and PET scans. Findings highlight the need to enhance radiology education for safer diagnostic practices and better patient outcomes. This research provides a foundation for future studies on radiologic knowledge.

5 December 2024 in Research Square
Verified
Preprint
Open access
PDF file
SSSimin Sajadi
Simin Sajadi
GRGholamreza Raissi
Gholamreza Raissi
MKmohmad mehdi khadembashiri
mohmad mehdi khadembashiri
KMKorosh Mansouri
Korosh Mansouri
HHHomayoun Hadizadeh-Kharazi
Homayoun Hadizadeh-Kharazi
SPSina Parsipour
Sina Parsipour
Background: Osteoarthritis (OA) is a degenerative joint disease that primarily affects older adults, characterized by cartilage degradation, synovitis, and osteophyte formation. Despite its prevalence, no medical treatment can reverse the joint cartilage degradation, leading many patients to undergo invasive procedures such as arthroplasty. Mesenchymal stem cells (MSCs), particularly those derived from adipose tissue, have emerged as a promising therapeutic approach due to their ability to differentiate into chondrocytes and potentially regenerate cartilage. While MSCs from bone marrow and umbilical cord have shown efficacy in treating OA, adipose-derived MSCs are more accessible and cost-effective. This study aims to evaluate the safety and efficacy of allogeneic adipose-derived MSCs in treating knee OA. Methods: This triple-blind, interventional clinical trial included 20 patients with idiopathic knee OA, meeting the American College of Rheumatology (ACR) criteria. Patients were randomly assigned to receive an intra-articular injection of either 8.5×10^6 allogeneic adipose-derived MSCs or saline (control group). Participants were evaluated for clinical signs of inflammation at baseline, and then at 2 weeks, 2 months, and 6 months post-injection using clinical assessments, the Visual Analogue Scale (VAS), Knee injury and Osteoarthritis Outcome Score (KOOS), range of motion (ROM), and Magnetic Resonance Arthrography (MRA). Results: The MSC group exhibited significant improvement in pain reduction as measured by VAS scores compared to the control group (P < 0.05). However, no significant differences were observed between the groups in ROM, quality of life, or daily activities as assessed by KOOS. Radiological outcomes showed a significant increase in cartilage thickness at specific locations (e.g., MLP, TCL) in the MSC group after 6 months, demonstrating the regenerative potential of MSCs in certain MRA sites. Conclusion: Allogeneic adipose-derived MSCs are safe and effective in reducing pain and increasing cartilage thickness in knee OA patients. However, they do not significantly enhance quality of life or daily activity compared to placebo. Further research with larger sample sizes and longer follow-up periods is needed to confirm these findings and determine optimal dosing strategies. Trial registration: Trial Registry Code: IRCT2016021123298N3, 20 February 2016. https://irct.behdasht.gov.ir/trial/19909

1 October 2025 in BMC Cardiovascular Disorders
Verified
Journal Article
Open access
PDF file
PRParvaneh Hamian Roumiani
Parvaneh Hamian Roumiani
MYMohammad Yaghoubi
Mohammad Yaghoubi
FNFateme Nozari
Fateme Nozari
MTMaryam Taheri
Maryam Taheri
MTMahgol Sadat Hassan Zadeh Tabatabaei
Mahgol Sadat Hassan Zadeh Tabatabaei
MKmohmad mehdi khadembashiri
mohmad mehdi khadembashiri
Myocarditis poses significant challenges in diagnosis and management due to its diverse etiology and clinical manifestations. Despite advances in medical care, myocarditis remains a leading cause of heart failure and sudden cardiac death worldwide, necessitating comprehensive understanding of its regional burden. This study aims to assess the incidence and burden of myocarditis in the Middle East and North Africa (MENA) region. Data were obtained from the Global Burden of Diseases Study 2019, utilizing standardized disease criteria and statistics collected by the Institute of Health Metrics and Evaluation (IHME). Global, regional, and national estimates of myocarditis mortality, incidence, and disability-adjusted life years (DALYs) were gathered for the period from 1990 to 2019. The Socio-demographic Index (SDI) was utilized as a measure of national development. The findings indicate a minor change in the age-standardized incidence rate (ASIR) of myocarditis over the three decades, while a notable decrease was observed in both the age-standardized mortality rate (ASMR) and age-standardized disability-adjusted rate (ASDR). Females exhibited higher ASMR and ASDR compared to males, despite similar ASIR trends. Country-level variations in myocarditis incidence were observed, with some nations experiencing increased rates, while others witnessed declines. Oman, Iraq, and Egypt had the highest ASMRs, whereas Bahrain, Jordan, and Turkey had the lowest. This study underscores the need for targeted interventions to mitigate the burden of myocarditis in the MENA region. The observed disparities in incidence and mortality rates highlight the complex interplay between socio-demographic factors and disease outcomes, emphasizing the importance of comprehensive public health strategies tailored to regional contexts. Further research is warranted to elucidate the underlying factors driving these disparities and inform effective intervention strategies.